Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2015 | 1 |
2019 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.
Lancet Oncol. 2022 Oct;23(10):1308-1320. doi: 10.1016/S1470-2045(22)00517-4. Epub 2022 Sep 13.
Lancet Oncol. 2022.
PMID: 36113498
Free article.
Clinical Trial.
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Brand DH, Tree AC, Ostler P, van der Voet H, Loblaw A, Chu W, Ford D, Tolan S, Jain S, Martin A, Staffurth J, Camilleri P, Kancherla K, Frew J, Chan A, Dayes IS, Henderson D, Brown S, Cruickshank C, Burnett S, Duffton A, Griffin C, Hinder V, Morrison K, Naismith O, Hall E, van As N; PACE Trial Investigators.
Brand DH, et al.
Lancet Oncol. 2019 Nov;20(11):1531-1543. doi: 10.1016/S1470-2045(19)30569-8. Epub 2019 Sep 17.
Lancet Oncol. 2019.
PMID: 31540791
Free PMC article.
Clinical Trial.
Item in Clipboard
Optimal patient selection for stereotactic body radiotherapy - Authors' reply.
Brand DH, Tree AC, Hall E, van As N; PACE Trial Investigators.
Brand DH, et al.
Lancet Oncol. 2019 Dec;20(12):e662. doi: 10.1016/S1470-2045(19)30747-8.
Lancet Oncol. 2019.
PMID: 31797788
No abstract available.
Item in Clipboard
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity.
Ratnakumaran R, Mohajer J, Withey SJ, H Brand D, Lee E, Loblaw A, Tolan S, van As N, Tree AC; PACE Trial Investigators.
Ratnakumaran R, et al.
Clin Transl Radiat Oncol. 2024 Mar 26;46:100769. doi: 10.1016/j.ctro.2024.100769. eCollection 2024 May.
Clin Transl Radiat Oncol. 2024.
PMID: 38586079
Free PMC article.
Item in Clipboard
The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study.
Ratnakumaran R, Hinder V, Brand D, Staffurth J, Hall E, van As N, Tree A; PACE Trial Investigators.
Ratnakumaran R, et al.
Cancers (Basel). 2023 Feb 17;15(4):1288. doi: 10.3390/cancers15041288.
Cancers (Basel). 2023.
PMID: 36831631
Free PMC article.
Item in Clipboard
Effect of right ventricular pacing lead site on left ventricular function in patients with high-grade atrioventricular block: results of the Protect-Pace study.
Kaye GC, Linker NJ, Marwick TH, Pollock L, Graham L, Pouliot E, Poloniecki J, Gammage M; Protect-Pace trial investigators.
Kaye GC, et al.
Eur Heart J. 2015 Apr 7;36(14):856-62. doi: 10.1093/eurheartj/ehu304. Epub 2014 Sep 4.
Eur Heart J. 2015.
PMID: 25189602
Clinical Trial.
Item in Clipboard
Cite
Cite